FormFactor Smashes Q2 Estimates on Unrelenting AI Demand, Margins Surge

What happened

FormFactor’s Q2 results saw revenue leap 32% year-over-year, driving gross margins up 1340 basis points to 50.7% and generating robust cash flow, a clear testament to surging AI-related demand for HBM, DRAM, and co-packaged optics test solutions. The strong performance, coupled with Q3 guidance well above consensus, dispels fears that AI-driven growth has peaked and confirms the company’s operational execution is delivering promised margin expansion. While the DeepValue report had flagged risks from tariffs and restructuring, the magnitude of the margin beat suggests those headwinds are being absorbed or offset by favorable mix and scale. The stock had already rallied into the print, and the results validate the bull thesis, but at elevated valuations, the market had priced in a beat. The report’s base-case implied value of $140 may now be raised, but discipline is needed as the stock nears the trim level.

Implication

FormFactor’s Q2 outperformance materially de-risks the margin expansion thesis and suggests AI test demand remains robust into the second half. Investors who held through the recent volatility should consider trimming positions as the stock approaches the $155 trim level outlined in the prior report. For those on the sidelines, a pullback toward the updated base-case value of $140 offers a more attractive risk/reward, given the ongoing tariff and restructuring uncertainties. The raised guidance and faster-than-expected margin recovery increase confidence that the Texas factory ramp and HBM4 transition will sustain growth through 2027. However, customer concentration and cyclicality remain inherent risks, so position sizing should reflect a still-elevated valuation multiple.

Thesis delta

The DeepValue thesis priced a WAIT rating conditional on Q2 execution; the beat lifts the probability of the bull scenario ($170) and reduces the bear case ($95). The attractive entry point adjusts upward to ~$140 from $110, while the trim level holds at $155. The conviction in operational execution improves, but the stock’s post-earnings run-up limits immediate upside.